Like us on Facebook Follow us on Twitter
News

To Finally Develop a Universal Flu Vaccine, Innovative Science and Financing Must Combine Forces

An article in Fortune by the Sabin-Aspen Group co-chairs makes the case for bringing together scientific, technological and financial talent and investment to accelerate a UIV.

Current vaccine manufacturing remains largely based on 1940s technology. Read this Fortune article authored by the Sabin-Aspen Vaccine Science & Policy Group co-chairs on the imperative for bringing together scientific, technological and financial talent and investment to accelerate a universal influenza vaccine and revolutionize vaccine development.

Read now

Close

Thank you for your interest.

We have received your email signup and you will get more information about the Influenzer Initiative and how you can help as it becomes available.

Please tell us more.

In order to send you the most relevant content, please provide us with some more details about you and the kind of work you do.

  • This field is for validation purposes and should be left unchanged.

We’re more powerful together.

Thanks for telling us more about yourself and joining the Influenzer community.

Back
Close

Stay informed

Influenzers come from many backgrounds. But we have one thing in common: we’re determined to prevent a global influenza pandemic that could take millions of lives. By bringing diverse ideas and unconventional thinking together, we can outsmart influenza.

Sign up to be the first to hear about exciting developments.

  • This field is for validation purposes and should be left unchanged.

We’re more powerful together.

Thanks for telling us more about yourself and joining the Influenzer community.

Back